Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Squeeze coming
View:
Post by LithLover on Apr 09, 2021 3:45pm

Squeeze coming

Once word about the testing and new updates comes out and the increased Q1 numbers this is gonna squeeze real noce.  Hope you guys get enough shares to cover your shorts.  You won't have too much more time before she runs and you will need to buy back.  Maybe create some new accounts that strategy seems to work  lol
Comment by RelevantStock on Apr 09, 2021 3:48pm
I agree this is so exagerated, a large buyer could drive these clowns out of business without too much difficulty, with a good pr.
Comment by LithLover on Apr 09, 2021 3:51pm
Yes they are doing everything they can to get shares and short this.  We all know this is going to be a beast just a matter of what happens in the next 4-5 weeks.
Comment by brad129 on Apr 09, 2021 4:32pm
absolutely no offence intended Lithlover, when does the next Q or next 5 weeks stop, we've all been hearing that for 5 years here, still holding(not so strong now)
Comment by Mykndrsn on Apr 09, 2021 4:37pm
As revenues continue to rise so will the sp. Yes it's that simple. 
Comment by brad129 on Apr 09, 2021 4:39pm
didn't the revenue just rise?  
Comment by Mykndrsn on Apr 09, 2021 4:46pm
Just the beginning. We have more revenue streams beyond Aristotle as of last Monday. Money talks.
Comment by brad129 on Apr 09, 2021 4:53pm
we will have more revenue from them, will also have more expense with them as well, question is which one will be greater? Do you happen to know their sales? Do you know what their net profit or loss was. Are we going to need to finance to support them as well. Lots of unanswered questions. By the way our sales just almost doubled, but here we are. 7million in the bank was end of December how much ...more  
Comment by davewho on Apr 09, 2021 5:27pm
James said on the CC that the acquistion would be immediately accretive which adds to our earnings once the deal closes. It would certainly be nice to see an initial order of Aristotle from Care. So far neither have updated their websites saying the test is available. Hopefully soon?  26k people die of cancer everyday as of 2018 stats. At least SZLS and Care are trying to do something about ...more  
Comment by Mykndrsn on Apr 09, 2021 5:46pm
Large margins tend to make expenses not much of an issue. Core, on two continents, seems to do quite well without Szlzs. Covid, Aristotle and Core are all contributing. 
Comment by valentinemasson on Apr 09, 2021 5:13pm
Too bad the market doesn't see it thst way.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities